GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Berry Genomics Co Ltd (SZSE:000710) » Definitions » Debt-to-Equity

Berry Genomics Co (SZSE:000710) Debt-to-Equity : 0.16 (As of Mar. 2025)


View and export this data going back to 1997. Start your Free Trial

What is Berry Genomics Co Debt-to-Equity?

Berry Genomics Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥130 Mil. Berry Genomics Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥134 Mil. Berry Genomics Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥1,667 Mil. Berry Genomics Co's debt to equity for the quarter that ended in Mar. 2025 was 0.16.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Berry Genomics Co's Debt-to-Equity or its related term are showing as below:

SZSE:000710' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02   Med: 0.16   Max: 1.07
Current: 0.16

During the past 13 years, the highest Debt-to-Equity Ratio of Berry Genomics Co was 1.07. The lowest was 0.02. And the median was 0.16.

SZSE:000710's Debt-to-Equity is ranked better than
64.02% of 189 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs SZSE:000710: 0.16

Berry Genomics Co Debt-to-Equity Historical Data

The historical data trend for Berry Genomics Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Berry Genomics Co Debt-to-Equity Chart

Berry Genomics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.16 0.15 0.16 0.10

Berry Genomics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.08 0.06 0.10 0.16

Competitive Comparison of Berry Genomics Co's Debt-to-Equity

For the Diagnostics & Research subindustry, Berry Genomics Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Berry Genomics Co's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Berry Genomics Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Berry Genomics Co's Debt-to-Equity falls into.


;
;

Berry Genomics Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Berry Genomics Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Berry Genomics Co's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Berry Genomics Co  (SZSE:000710) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Berry Genomics Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Berry Genomics Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Berry Genomics Co Business Description

Traded in Other Exchanges
N/A
Address
Life Park Road, Building 5, Courtyard 4, Science and Technology Park, Changping District, Beijing, CHN
Berry Genomics Co Ltd is a biotechnology company. It providess gene sequencing detection equipment and services.
Executives
Gao Yang Directors, executives
Hou Ying Directors, executives
Wang Yu Jing Supervisors
Wang Dong Directors, executives
Zhou Dai Xing Directors, executives
Ou Yang Xiang Yu Supervisors
Li Guang Chao Independent director
Gu Zhong Guo Directors, executives
Wen Wu Director
Ding Xian Xing Supervisors

Berry Genomics Co Headlines

No Headlines